Sector: MedicalIndevus Pharmaceuticals Inc. (NASDAQ: IDEV)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 139 |
Technical : | 142 |
Performance : | 225 |
Overall: | 201 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 139 |
Technical : | 152 |
Performance : | 235 |
Overall: | 213 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 141 |
Technical : | 140 |
Performance : | 236 |
Overall: | 207 |
Number of Stocks: | 305 |
Headlines
- In Search of Healthcare Diamonds In The Rough
Jan 12, 2009 12:57 AM | ACHN, AKRX, BPA, CYNO, DNA, ENDP
- Weekly Mergers and Acquisitions Report - 01-06-2009
Jan 07, 2009 09:32 AM | CTL, DSCP, ENDP, EQ, EXC, IDEV
- Sykes Says: Some Suppressive SEC Short Selling Scrap Stocks Suckas!
Oct 02, 2008 12:20 PM | BBX, EFJI, IDEV, SIL, WAT
- Eight White Hot Stocks You Should Know About
Sep 29, 2008 10:58 AM | CCOW, CYPB, IDEV, SIL
- Indevus Pharmaceuticals, Inc. : The Subway Stock Trader Pick of the Day
Sep 26, 2008 12:30 PM | IDEV
- TapImmune Issued U.S. Patent Relating to Methods for Enhancing an Immune Response and Alseres Pharmaceuticals, Inc. Raises $5 Million
Jul 01, 2008 09:00 AM | GENR, IDEV
- Indevus Gets Nonapprovable Letter On Testosterone Drug
Jun 30, 2008 11:14 AM | IDEV
- Indevus Gets Approvable Letter On Testosterone Drug
Jun 30, 2008 11:14 AM | IDEV
- Obagi Medical rises on analyst 'Buy' rating and Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
May 21, 2008 09:29 AM | IDEV, OMPI
- Obagi Medical rises on analyst 'Buy' rating and Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
May 21, 2008 09:29 AM | IDEV, OMPI
- Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Mar 19, 2009 08:55 AM | ENDP, IDEV
- Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009
Mar 16, 2009 08:58 AM | ENDP, IDEV
- FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Mar 12, 2009 09:53 AM | IDEV
- Burns & Levinson Guides Indevus Through Significant Pharmaceutical Transaction
Mar 10, 2009 12:35 AM | ENDP, IDEV
- Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
Mar 02, 2009 08:32 AM | ENDP, IDEV
- Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results
Feb 04, 2009 04:37 PM | IDEV
- Zacks Analyst Blog Highlights: Sohu.Com, Inc., Priceline.Com, Dollar Financial Corp., Indevus Pharmaceuticals and Endo Pharmaceuticals.
Jan 12, 2009 07:18 AM | DLLR, ENDP, IDEV, PCLN, SOHU
- BenchmarkJournal.Com (Complimentary) Analyst Review for IDEV, AMED, ENDP and CIEN
Jan 06, 2009 11:20 AM | AMED, CIEN, ENDP, IDEV
- Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Jan 05, 2009 04:51 PM | IDEV
- Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
Jan 05, 2009 04:30 PM | ENDP, IDEV
- Form 4 Endo Pharmaceuticals For: Mar 23 Filed by: ENDO PHARMACEUTICALS HOLDINGS INC (10K)
Mar 23, 2009 06:55 PM
- Form 4 INDEVUS PHARMACEUTICALS For: Mar 20 Filed by: ENDO PHARMACEUTICALS HOLDINGS INC (10K)
Mar 20, 2009 04:41 PM
- Form 4 INDEVUS PHARMACEUTICALS For: Mar 05 Filed by: BTB Purchaser Inc. (10K)
Mar 09, 2009 10:58 PM
- Form 4/A INDEVUS PHARMACEUTICALS For: Feb 24 Filed by: BTB Purchaser Inc. (10K)
Mar 09, 2009 10:57 PM
- Form 4 INDEVUS PHARMACEUTICALS For: Feb 25 Filed by: PERCEPTIVE ADVISORS LLC (10K)
Mar 09, 2009 06:10 PM
- Form 4 INDEVUS PHARMACEUTICALS For: Feb 24 Filed by: BTB Purchaser Inc. (10K)
Mar 04, 2009 06:58 PM
- Form 3/A INDEVUS PHARMACEUTICALS For: Feb 23 Filed by: BTB Purchaser Inc. (10K)
Mar 04, 2009 06:56 PM
- Form 3 Wysenski Nancy For: Feb 23 (10K)
Mar 03, 2009 07:31 PM
- Form 3 Holveck David For: Feb 23 (10K)
Mar 03, 2009 07:31 PM
- Form 3 Gergel Ivan P. For: Feb 23 (10K)
Mar 03, 2009 07:30 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
IDEV
|
Compare to S&P
|
| YTD |
-0.01 %
|
124.58 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 44.44 %
|
|
EPS Growth in Last Year: 47.37 %
|
|
Sales Growth in Last Quarter: 13.15 %
|
|
Sales Growth in Last Quarter: 60.98 %
|
|
